Fig. 5From: Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancerComparison of the changes in CD8+CD122+ T cell after chemotherapy between PR + SD and PD groups using the paired t-test with the Wilcoxon signed-rank test. Pre: before chemotherapy, post: 2 months after chemotherapy induction. *P < 0.05, **P < 0.01, NS: not significantBack to article page